Cleared Traditional

K914172 - KPE 230 AM

K914172 is an FDA 510(k) clearance for KPE 230 AM, manufactured by Ipax, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K914172 · Ipax, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1991
Decision
60d
Days
Class 2
Risk

K914172 is an FDA 510(k) clearance for the KPE 230 AM. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Ipax, Inc. (Englewood, US). The FDA issued a Cleared decision on October 25, 1991 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ipax, Inc. devices

FDA 510(k) Submission Details - K914172

510(k) Number K914172 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 26, 1991
Decision Date October 25, 1991
Days to Decision 60 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 110d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 123
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K914172.
IOLAB REUSABLE PERISTATIC CASSETTE/OPHTHALMIC USE
K921607 · Chiron Vision Corp. · Jun 1992
IOLAB POWER I.V. POLE
K921135 · Site Microsurgical Systems, Inc. · Jun 1992
PHACOEMULSIFICATION SYSTEM FOR OPHTHALMIC USE
K912902 · Site Microsurgical Systems, Inc. · Dec 1991
LOOK VISCODISSECTOR
K913530 · Look, Inc. · Oct 1991
SITE 90 TIP, I/A HANDPIECE .3MM SIDE OPEN/OPTH USE
K912739 · Site Microsurgical Systems, Inc. · Aug 1991
GEMINI OPHTHALMIC SURGERY SYSTEM
K911808 · Alcon Laboratories · Jun 1991